Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection.

Le infezioni in medicina - 1 Jun 2021

Sica Antonello, Spada Alessandro, Sagnelli Caterina, Verolino Pasquale, Mazzocca Annalisa, Sagnelli Evangelista, Colella Giuseppe, Guastafierro Salvatore, Marrone Aldo

Abstract excerpt

Patients with indolent non-Hodgkin lymphomas (NHL) may often be followed up only with observation, reserving chemotherapy in case of spread. Patients with chronic HCV infection and B cell NHL frequently undergo regression of lymphoproliferative disease once HCV infection is eradicated by treatment. Interferon (IFN)-based therapy has been the treatment of choice for years, remaining unclear whether it is effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Benzofurans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepatitis C, Chronic

Share to Imidazoles

Share to Lymphoma, Non-Hodgkin

Share to Sustained Virologic Response

Source

Identifiers

PMID: 34061795

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection.PMID 34061795Read ↗

Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.Semantic proximity Read ↗

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.Semantic proximity Read ↗

Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.Semantic proximity Read ↗

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.Semantic proximity Read ↗

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.Semantic proximity Read ↗

HCV and LymphoproliferationSemantic proximity Read ↗

Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisation.Semantic proximity Read ↗

IGHV1-69 BCRs with virus-neutralizing mutations show lymphoma-like transcriptomes in patients with chronic HCV infectionSemantic proximity Read ↗

Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection.Semantic proximity Read ↗

B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection.Semantic proximity Read ↗

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.Semantic proximity Read ↗

IFNL3 expression and response to treatment: behind the HCV tricks.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.